We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
A new world is possible. Let's not go back to what wasn't working anyway.
Add this topic to your myFT Digest for news straight to your inbox
WHO-backed programme has cut its projected deliveries following setbacks
It is time to overhaul the way we train, recruit and retain doctors, nurses and care staff
Infection and death rates are the world’s highest and vaccination take-up is low, forcing renewed restrictions
Concern over booster campaign as advisers urge government to prepare for ‘rapid deployment’ of tighter Covid restrictions
Vaccine drive described as ‘fragmented’ with half the people eligible for third dose yet to come forward
Competition and Markets Authority warns over inadequate supply and high debt levels among private equity-owned operators
US regulatory shake-up will mainly effect people who would otherwise have gone without
Excessive boosterism and US partisan divisions risk undermining a limited but effective therapy
Results hailed as ‘important’ but duration of protection still unknown
Move against Malaysia’s Supermax follows UK claims that health service procurements have passed due diligence
Unvaccinated employees must soon submit to weekly checks, straining short supply
British Medical Association claims UK government is being ‘wilfully negligent’ in refusing to act
Narendra Modi celebrates ‘triumph of Indian science’ months after devastating second wave
14m baby-boomers heading towards retirement is a good reason to look at healthcare
People at high risk of catching coronavirus can now receive any of three vaccines authorised by US health agency
Health secretary urges people to get booster jabs to avoid fresh restrictions
Third-quarter revenues from $56,000-per-year treatment were well below analysts’ expectation of $10m
Demand comes as daily death toll hits highest level since March and hospitalisations near 1,000
Stable funding for work on less glamorous diseases would make the system fairer and more resilient
Suggestion ex-secretary of state would have benefited from treatment dismissed as ‘highly speculative’
New half-term vaccine push for teens comes as ministers question progress of third-jab programme
Boston-based EQRx wants to sell medicines at prices 50-70 per cent below rivals
Healthcare group created a subsidiary to manage allegations then placed it into bankruptcy
Trial results come month after UK terminated contract with French company
International Edition
